Tag: pancreatic cancer

trisalus

TriSalus presents preclinical data on proprietary infusion technology at SIR 2022

TriSalus’ clinical leadership team presented new preclinical data at the Society of Interventional Radiology (SIR) 2022 Annual Scientific Meeting (11–16 June, Boston, USA). The...
trisalus

First patient enrolled in PERIO-02 trial of SD-101 delivery via pressure-enabled...

TriSalus Life Sciences announced the enrolment of the first patient in its Pressure-Enabled Regional Immuno-Oncology (PERIO-02) clinical study in a press release.  The trial is...
Interventional News for specialists

Y90 radioembolization shows promise in treating metastatic pancreatic cancer

Encouraging results from Y90 (yttrium-90) radioembolization of pancreatic cancer support a possible role for it in the management of the disease, with initial small...

Early data finds image-guided ablation “feasible and well tolerated” for oligometastatic...

A retrospective review of single-institution experience, published in July in the Journal of Vascular and Interventional Radiology (JVIR), suggests that percutaneous image-guided ablation is...

Identification of pancreatic cancer pathway could broach new era of effective...

Pancreatic Cancer Action Network (PanCAN) grantee George Miller, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department...